On Sholay's 50th anniversary, Iran's leading daily dedicated a full-page tribute to the Bollywood classic. Here is why Sholay ...

Texas leaders broke promises to hold CenterPoint accountable after Hurricane Beryl. Here are 5 takeaways. By Claire Hao, Neena Satija, Staff writersJune 26, 2025 ...

Kennedy's US vaccine panel backs preservative-free shot despite safety evidence By Bhanvi Satija and Michael Erman June 27, 20257:39 AM PDTUpdated June 27, 2025 ...

By Bhanvi Satija and Christy Santhosh (Reuters) -The U.S. Centers for Disease Control and Prevention posted a report on Tuesday that said evidence does not support a link between thimerosal ...

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending shares of the U.S. telehealth company plunging more than 30%.

The companies had announced a collaboration in April for Hims & Hers to sell Novo's Wegovy through an offering on the telehealth company's platform.

Shares of Sarepta Therapeutics closed down as much as 42% to hit a nine-year low of $18.30 on Monday after a second death of a male teenage patient who had received its gene therapy, Elevidys ...

Supernus Pharmaceuticals will acquire Sage Therapeutics in a deal worth up to $795 million to gain access to the only postpartum depression pill approved in the United States.

The latest Mitch Little news from The Texas Tribune. By Dylan McGuinness, Neena Satija and Matt Zdun, Houston Chronicle June 13, 2025 Texans for Lawsuit Reform is threatening to primary House ...

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

Vaccine stocks muted as investors assess Kennedy's overhaul of key panel By Sriparna Roy and Bhanvi Satija June 10, 20259:47 AM PDTUpdated June 10, 2025 ...